Brief: Captor Therapeutics Signs Deal With EISMEA For Funding Of Ct-03 Aml Trials Project
24/10/2025 17:36
Oct 24 (Reuters) - Captor Therapeutics SA CTXP.WA: SIGNS AGREEMENT WITH EISMEA FOR 7.8 MILLION FUNDING FOR CT-03 AML TRIALS PROJECT FUNDING INCLUDES GRANT OF EUR 2.5 MILLION AND POSSIBLE PARTICIPATION OF EUROPEAN INVESTMENT BANK IN POSSIBLE SHARE ISSUE OF EUR 5.3 MILLION Source text: ID:nEM3sPhdPa Further company coverage: CTXP.WA (Reporting by Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Captor Therapeutics SA
See all newsBrief: Captor Therapeutics To Issue 8934 Series Z Shares For Incentive Programme Purpose
Brief: Captor Therapeutics Q1 Net Loss At 11.4 Million Zlotys
Brief: Captor Therapeutics FY Net Loss At 42.0 Million Zlotys
Brief: Captor Therapeutics To Sell 800,000 Y Series Shares At 82 Zlotys/Shr
Brief: Captor Therapeutics Starts ABB Process For Up To 800,000 New Series Y Shares